E. Fatta

1.3k total citations · 1 hit paper
15 papers, 917 citations indexed

About

E. Fatta is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, E. Fatta has authored 15 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Hepatology and 4 papers in Hematology. Recurrent topics in E. Fatta's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (5 papers) and Iron Metabolism and Disorders (4 papers). E. Fatta is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (5 papers) and Iron Metabolism and Disorders (4 papers). E. Fatta collaborates with scholars based in Italy, Netherlands and Taiwan. E. Fatta's co-authors include Anna Ludovica Fracanzani, Silvia Fargion, Luca Valenti, C. Bertelli, Ester Vanni, Giulio Marchesini, Elisabetta Bugianesi, Daniela Bignamini, Agostino Colli and M. Andreoletti and has published in prestigious journals such as Hepatology, Journal of Hepatology and Nutrients.

In The Last Decade

E. Fatta

15 papers receiving 893 citations

Hit Papers

Risk of severe liver disease in nonalcoholic fatty liver ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Fatta Italy 9 750 370 272 139 131 15 917
C. Bertelli Italy 13 856 1.1× 398 1.1× 324 1.2× 158 1.1× 124 0.9× 22 1.1k
Daniela Bignamini Italy 6 553 0.7× 299 0.8× 208 0.8× 107 0.8× 314 2.4× 12 1000
Shehan Abeygunasekera Australia 4 995 1.3× 560 1.5× 268 1.0× 177 1.3× 45 0.3× 5 1.1k
Heike Haufe Austria 10 402 0.5× 155 0.4× 129 0.5× 72 0.5× 133 1.0× 17 721
Gennaro Santorelli Italy 7 446 0.6× 240 0.6× 110 0.4× 84 0.6× 63 0.5× 11 540
D. K. George Australia 9 484 0.6× 159 0.4× 187 0.7× 92 0.7× 253 1.9× 15 859
Tetsuhei Ogawa Japan 10 367 0.5× 217 0.6× 132 0.5× 116 0.8× 53 0.4× 35 654
Michihiko Shibata Japan 10 251 0.3× 140 0.4× 129 0.5× 93 0.7× 31 0.2× 62 520
Smruti R. Mohanty United States 12 577 0.8× 169 0.5× 263 1.0× 67 0.5× 12 0.1× 34 769
Xiaomin Pan United States 10 265 0.4× 105 0.3× 97 0.4× 37 0.3× 103 0.8× 16 574

Countries citing papers authored by E. Fatta

Since Specialization
Citations

This map shows the geographic impact of E. Fatta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Fatta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Fatta more than expected).

Fields of papers citing papers by E. Fatta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Fatta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Fatta. The network helps show where E. Fatta may publish in the future.

Co-authorship network of co-authors of E. Fatta

This figure shows the co-authorship network connecting the top 25 collaborators of E. Fatta. A scholar is included among the top collaborators of E. Fatta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Fatta. E. Fatta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lombardi, Rosa, Annalisa Cespiati, E. Fatta, et al.. (2023). Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades. Digestive and Liver Disease. 56(1). 144–151. 2 indexed citations
2.
Cespiati, Annalisa, Rosa Lombardi, Andrea Costantino, et al.. (2022). Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. Nutrients. 14(3). 556–556. 13 indexed citations
3.
Cespiati, Annalisa, Salvatore Petta, Rosa Lombardi, et al.. (2020). Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Digestive and Liver Disease. 53(10). 1301–1307. 13 indexed citations
4.
Rametta, Raffaela, Paola Dongiovanni, Serena Pelusi, et al.. (2016). Hepcidin resistance in dysmetabolic iron overload. Liver International. 36(10). 1540–1548. 31 indexed citations
5.
Lombardi, Rosa, Giuseppina Pisano, Paola Dongiovanni, et al.. (2016). Lean-Non-Alcoholic Fatty Liver Disease with Central Visceral Obesity Identifies Patients with More Severe Disease. Journal of Hepatology. 64(2). S191–S192. 1 indexed citations
6.
Lombardi, Rosa, Luca Valenti, C. Bertelli, et al.. (2011). T-12 Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: A possible marker of metabolic syndrome and early vascular damage. Digestive and Liver Disease. 43. S80–S81. 2 indexed citations
7.
Valenti, Luca, Dorine W. Swinkels, Paola Dongiovanni, et al.. (2010). Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutrition Metabolism and Cardiovascular Diseases. 21(8). 568–575. 75 indexed citations
8.
Fracanzani, Anna Ludovica, Luca Valenti, Elisabetta Bugianesi, et al.. (2010). Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. Journal of Hepatology. 54(6). 1244–1249. 95 indexed citations
9.
Lampertico, Pietro, Mauro Viganò, F. Facchetti, et al.. (2009). Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients: A large multicenter cohort study in clinical practice. Digestive and Liver Disease. 41(3). A6–A7. 3 indexed citations
10.
Fracanzani, Anna Ludovica, Luca Valenti, Elisabetta Bugianesi, et al.. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology. 48(3). 792–798. 530 indexed citations breakdown →
12.
Fracanzani, Anna Ludovica, Silvia Fargion, Maria Antonietta Stazi, et al.. (2005). Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma. Blood Cells Molecules and Diseases. 35(1). 27–32. 19 indexed citations
13.
Valenti, Luca, Paola Dongiovanni, Anna Ludovica Fracanzani, et al.. (2003). Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Digestive and Liver Disease. 35(3). 172–178. 74 indexed citations
14.
Valenti, Luca, E.A. Pulixi, Anna Ludovica Fracanzani, et al.. (2003). TNFalpha promoter polymorphisms and insulin resistance in HCV-related liver disease. Journal of Hepatology. 38. 178–178. 1 indexed citations
15.
Fracanzani, Anna Ludovica, Emanuela Taioli, Maurizio Sampietro, et al.. (2001). Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. Journal of Hepatology. 35(4). 498–503. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026